24/7 MN – (NASDAQ:ALDX) shares are up this morning on top line results from a clinical study, shares are at$5.11 this morning and poised to move up

July 12, 2022

[mstock id=”73007″ asset=ALDX”]

Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from the Dry Eye Disease Chamber Crossover Clinical Trial of Reproxalap

https://www.businesswire.com/news/home/20220711005532/en/Aldeyra-Therapeutics-Schedules-Conference-Call-and-Webcast-to-Announce-Top-Line-Results-from-the-Dry-Eye-Disease-Chamber-Crossover-Clinical-Trial-of-Reproxalap

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.